Cargando…

Novel antibody against low‐n oligomers of tau protein promotes clearance of tau in cells via lysosomes

INTRODUCTION: Tau, a natively unfolded soluble protein, forms abnormal oligomers and insoluble filaments in several neurodegenerative diseases, including Alzheimer disease (AD). Tau‐induced toxicity is mainly due to oligomers rather than monomers or fibrils. METHODS: We have developed monoclonal ant...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chandupatla, Ram Reddy, Flatley, Andrew, Feederle, Regina, Mandelkow, Eva‐Maria, Kaniyappan, Senthilvelrajan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7593557/ https://www.ncbi.nlm.nih.gov/pubmed/33145390 http://dx.doi.org/10.1002/trc2.12097

Ejemplares similares

Suppressing Tau Aggregation and Toxicity by an Anti-Aggregant Tau Fragment
por: Pir, Ghulam Jeelani, et al.
Publicado: (2018)

FRET-based Tau seeding assay does not represent prion-like templated assembly of Tau filaments
por: Kaniyappan, Senthilvelrajan, et al.
Publicado: (2020)

The release and trans-synaptic transmission of Tau via exosomes
por: Wang, Yipeng, et al.
Publicado: (2017)

Potent Tau Aggregation Inhibitor D‐Peptides Selected against Tau‐Repeat 2 Using Mirror Image Phage Display
por: Malhis, Marwa, et al.
Publicado: (2021)

A novel D-amino acid peptide with therapeutic potential (ISAD1) inhibits aggregation of neurotoxic disease-relevant mutant Tau and prevents Tau toxicity in vitro
por: Aillaud, Isabelle, et al.
Publicado: (2022)

Spreading of Tau Protein Does Not Depend on Aggregation Propensity
por: Rodrigues, Sara, et al.
Publicado: (2023)

Stages and Conformations of the Tau Repeat Domain during Aggregation and Its Effect on Neuronal Toxicity
por: Kumar, Satish, et al.
Publicado: (2014)

A combinatorial native MS and LC-MS/MS approach reveals high intrinsic phosphorylation of human Tau but minimal levels of other key modifications
por: Drepper, Friedel, et al.
Publicado: (2021)

Reversal of Tau-Dependent Cognitive Decay by Blocking Adenosine A1 Receptors: Comparison of Transgenic Mouse Models with Different Levels of Tauopathy
por: Anglada-Huguet, Marta, et al.
Publicado: (2023)

Oligomer Formation of Tau Protein Hyperphosphorylated in Cells
por: Tepper, Katharina, et al.
Publicado: (2014)

A mechanistic model of tau amyloid aggregation based on direct observation of oligomers
por: Shammas, Sarah L., et al.
Publicado: (2015)

Molecular crowding and RNA synergize to promote phase separation, microtubule interaction, and seeding of Tau condensates
por: Hochmair, Janine, et al.
Publicado: (2022)

Characteristics of Tau Oligomers
por: Ren, Yan, et al.
Publicado: (2013)

Tau Oligomers Neurotoxicity
por: Niewiadomska, Grazyna, et al.
Publicado: (2021)

Hyperphosphorylation-Induced Tau Oligomers
por: Iqbal, Khalid, et al.
Publicado: (2013)

The dual fates of exogenous tau seeds: Lysosomal clearance versus cytoplasmic amplification
por: Kolay, Sourav, et al.
Publicado: (2022)

Inhibition of Tau aggregation with BSc3094 reduces Tau and decreases cognitive deficits in rTg4510 mice
por: Anglada‐Huguet, Marta, et al.
Publicado: (2021)

Extracellular Monomeric Tau Protein Is Sufficient to Initiate the Spread of Tau Protein Pathology
por: Michel, Claire H., et al.
Publicado: (2014)

Anti-aggregant tau mutant promotes neurogenesis
por: Joseph, Maria, et al.
Publicado: (2017)

Antibody-mediated clearance of tau in primary mouse microglial cultures requires Fcγ-receptor binding and functional lysosomes
por: Andersson, Christian Rungsted, et al.
Publicado: (2019)

Alzheimer brain-derived tau oligomers propagate pathology from endogenous tau
por: Lasagna-Reeves, Cristian A., et al.
Publicado: (2012)

Rescue from tau-induced neuronal dysfunction produces insoluble tau oligomers
por: Cowan, Catherine M., et al.
Publicado: (2015)

The Role of Protein Misfolding and Tau Oligomers (TauOs) in Alzheimer’s Disease (AD)
por: Mroczko, Barbara, et al.
Publicado: (2019)

Tau oligomers in cerebrospinal fluid in Alzheimer's disease
por: Sengupta, Urmi, et al.
Publicado: (2017)

Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage
por: Shafiei, Scott S., et al.
Publicado: (2017)

PIKfyve activity is required for lysosomal trafficking of tau aggregates and tau seeding
por: Soares, Alberto Carpinteiro, et al.
Publicado: (2021)

Baicalein inhibits heparin-induced Tau aggregation by initializing non-toxic Tau oligomer formation
por: Sonawane, Shweta Kishor, et al.
Publicado: (2021)

Tau fibrils induce nanoscale membrane damage and nucleate cytosolic tau at lysosomes
por: Rose, Kevin, et al.
Publicado: (2023)

Disease‐Associated Tau Phosphorylation Hinders Tubulin Assembly within Tau Condensates
por: Savastano, Adriana, et al.
Publicado: (2020)

Tau Oligomers: The Toxic Player at Synapses in Alzheimer’s Disease
por: Guerrero-Muñoz, Marcos J., et al.
Publicado: (2015)

Preparation of stable tau oligomers for cellular and biochemical studies
por: Karikari, Thomas K., et al.
Publicado: (2019)

Oligomer Diversity during the Aggregation of the Repeat Region of Tau
por: Kjaergaard, Magnus, et al.
Publicado: (2018)

Toxic Tau Oligomers Modulated by Novel Curcumin Derivatives
por: Lo Cascio, Filippa, et al.
Publicado: (2019)

The prion-like transmission of tau oligomers via exosomes
por: Jackson, Noel A., et al.
Publicado: (2022)

Extracellular Tau Oligomers Damage the Axon Initial Segment
por: Best, Merci N., et al.
Publicado: (2023)

Structure and regulation of MARK, a kinase involved in abnormal phosphorylation of Tau protein
por: Timm, Thomas, et al.
Publicado: (2008)

Identification of Small Molecule Inhibitors of Tau Aggregation by Targeting Monomeric Tau As a Potential Therapeutic Approach for Tauopathies
por: Pickhardt, Marcus, et al.
Publicado: (2015)

Amyloid β-protein oligomers promote the uptake of tau fibril seeds potentiating intracellular tau aggregation
por: Shin, Woo Shik, et al.
Publicado: (2019)

Endo-lysosomal Aβ concentration and pH trigger formation of Aβ oligomers that potently induce Tau missorting
por: Schützmann, Marie P., et al.
Publicado: (2021)

Acetylation of the KXGS motifs in tau is a critical determinant in modulation of tau aggregation and clearance
por: Cook, Casey, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_9qc076bhnehflud021p26pfqvn